Moderna Inc. Stock Advances 4.1%, Outperforms Peers
Dow Jones2026/10/19 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Moderna Inc. rallied 4.1% to $226.88 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 1.1% to 26,430.89 and the Dow Jones Industrial Average falling 0.1% to 51,966.03.
Moderna Inc. closed 6.4% short of its 52-week high of $242.29, which the company achieved on October 15th.
The stock outperformed some of its peers, as Johnson & Johnson fell 0.7% to $253.79, Pfizer Inc. fell 0.5% to $29.44, and Gilead Sciences Inc. fell 1.97% to $153.11.
Trading volume totaled 18.7 million, compared to the 50-day average of 23.1 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 19, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Oil prices surge as the biggest boost! Marathon Petroleum (MPC.US) up over 200% this year, outperforming major chip giants; shares hit a 52-week high and remain bullish
Marathon Petroleum has performed exceptionally well this year, with its stock price surging over 200% since the beginning of the year, outpacing even leading technology companies and chip manufacturers.
Chip Stocks Lost $2 Trillion in 8 Days, Testing Investor Faith in the AI Boom
BNP Paribas: Software distributor survey shows positive signals, Oracle (ORCL.US) is reaching a "remarkable inflection point"
The latest software distributor survey released by BNP Paribas indicates that Oracle is at a "noteworthy inflection point," partly driven by the support of generative artificial intelligence (GenAI).
Crypto prices
More
